share_log

復星醫藥：於股東周年大會、2024年第一次A股類別股東會及2024年第一次H股類別股東會所提呈決議案的投票結果派發末期股息及暫停辦理H股股東名冊登記

FOSUN PHARMA: POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE AGM THE 2024 FIRST A SHAREHOLDERS' CLASS MEETING AND THE 2024 FIRST H SHAREHOLDERS' CLASS MEETING DISTRIBUTION OF FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS FOR H SHARES

HKEX ·  Jun 26 20:34
Summary by Futu AI
復星醫藥於2024年6月26日舉行的股東周年大會、A股類別股東會及H股類別股東會中，通過了包括年度報告、財務決算報告、利潤分配預案、董事考核結果和報酬、以及修訂公司章程等多項決議案。會議在上海天禧嘉福璞緹客酒店依次召開，並由董事長吳以芳先生主持。出席股東代表對所有提呈的普通決議案均投下贊成票，特別決議案也獲得了超過三分之二的贊成票數，從而正式通過。此外，公司宣佈將派發截至2023年12月31日止年度的末期股息，每股人民幣0.27元（稅前），A股股東以人民幣支付，H股股東則以港幣支付，並將於2024年8月23日向股東派發。公司亦確認了股息派發的稅務處理方式，包括代扣代繳所得稅的安排。
復星醫藥於2024年6月26日舉行的股東周年大會、A股類別股東會及H股類別股東會中，通過了包括年度報告、財務決算報告、利潤分配預案、董事考核結果和報酬、以及修訂公司章程等多項決議案。會議在上海天禧嘉福璞緹客酒店依次召開，並由董事長吳以芳先生主持。出席股東代表對所有提呈的普通決議案均投下贊成票，特別決議案也獲得了超過三分之二的贊成票數，從而正式通過。此外，公司宣佈將派發截至2023年12月31日止年度的末期股息，每股人民幣0.27元（稅前），A股股東以人民幣支付，H股股東則以港幣支付，並將於2024年8月23日向股東派發。公司亦確認了股息派發的稅務處理方式，包括代扣代繳所得稅的安排。
At the annual shareholder meeting, A-share and H-share category shareholder meeting held by Fosun Pharma on June 26, 2024, multiple resolutions including the annual report, financial statement, profit distribution plan, director assessment results and compensation, and amendment to the company's articles of association were passed. The meeting was successively held at the Tianxi Jiafu Puti Ke Hotel in Shanghai and presided over by Mr. Wu Yifang, the chairman of the board. Shareholder representatives attending the meeting voted in favor of all ordinary resolutions submitted, and the special resolution also received more than two-thirds of the votes in favor, thus officially passed. In addition, the company announced the distribution of dividends for the year ending December 31, 2023, at RMB 0.27 (before tax) per share, paid in RMB for A-shares and in HKD for H-shares, which will be distributed to shareholders on August 23, 2024. The company also confirmed the tax treatment of dividend payments, including arrangements for withholding and paying income tax.
At the annual shareholder meeting, A-share and H-share category shareholder meeting held by Fosun Pharma on June 26, 2024, multiple resolutions including the annual report, financial statement, profit distribution plan, director assessment results and compensation, and amendment to the company's articles of association were passed. The meeting was successively held at the Tianxi Jiafu Puti Ke Hotel in Shanghai and presided over by Mr. Wu Yifang, the chairman of the board. Shareholder representatives attending the meeting voted in favor of all ordinary resolutions submitted, and the special resolution also received more than two-thirds of the votes in favor, thus officially passed. In addition, the company announced the distribution of dividends for the year ending December 31, 2023, at RMB 0.27 (before tax) per share, paid in RMB for A-shares and in HKD for H-shares, which will be distributed to shareholders on August 23, 2024. The company also confirmed the tax treatment of dividend payments, including arrangements for withholding and paying income tax.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.